By Maksym Misichenko · Nasdaq ·
What AI agents think about this news
The panel consensus is bearish, with key concerns being the dual dependencies on Starship physics breakthroughs and Starlink monetization, and the risk of extended negative FCF past 2027.
Risk: Extended negative FCF past 2027 due to delayed Starlink monetization and regulatory hurdles.
Opportunity: Achieving proven profitability from Starlink enterprise/government deals and successful Starship cadence targets by 2027-2028.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
Space Exploration Technologies (NASDAQ: SPCX) has accumulated $41.3 billion in total losses since its founding. In the first quarter of 2026 alone, the company posted a net loss of $4.28 billion -- nearly matching its full-year 2025 loss in a single quarter. The xAI division, absorbed in an all-stock deal earlier this year, generated $818 million in revenue against $2.47 billion in operating losses. Morningstar's discounted cash flow model places the company's fair value at $63 per share, roughly 59% below where the stock trades today.
None of this means SpaceX isn't building remarkable technology. It means investors are being asked to pay a record price for a company that hasn't demonstrated it can generate returns at scale. That's a risk category most portfolios don't need. The aerospace sector, though, is full of businesses that do exactly what SpaceX promises and already have the profit margins to prove it.
Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a "Double Down" signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same "Total Conviction" signal is flashing for a company 1/100th the size of Nvidia. Continue »
Here are four of them.
GE Aerospace (NYSE: GE) is arguably the best-positioned aviation company in the world right now, and the numbers back that up. In Q1 2026, the company reported orders of $17.3 billion -- up 93% year over year -- and revenue of $8.9 billion, up 29%. CEO Larry Culp described it as a "strong quarter with double-digit growth in earnings" driven by commercial engine demand. Its commercial backlog now stands at $190 billion, representing years of locked-in revenue from fleet replacements and aftermarket service contracts. The story here is a commercial aviation supercycle: Airlines that deferred aircraft purchases during the COVID-19 pandemic are now replacing aging fleets with fuel-efficient aircraft powered by GE LEAP and GE9X engines. That cycle has years of runway.
TransDigm Group (NYSE: TDG) sells highly engineered, sole-source aerospace components, the kind of parts that go inside commercial and military aircraft and have no practical substitute.
When an airline operates a Boeing 737 for 25 years, TransDigm collects revenue on the proprietary components inside that aircraft at every maintenance interval, for the life of the plane. The company reported Q1 fiscal 2026 results in February that showed aftermarket revenue growth continuing to compound. TransDigm's business model produces the kind of recurring, pricing-power-driven cash flow that growth-stage space companies are still trying to describe in hypothetical terms.
Howmet Aerospace (NYSE: HWM) makes the titanium and nickel alloy structural components that go inside jet engines -- the parts that sit inside the hottest sections of the most demanding propulsion systems on Earth. In Q1 2026, revenue grew 19% year over year to $2.31 billion, adjusted EPS grew 42% to $1.22, and the company beat Wall Street estimates by nearly 10%. CEO John Plant has built one of the most consistent operating records in industrial manufacturing. Every wide-body aircraft that Airbus and Boeing are accelerating into production runs on components that Howmet supplies. As the commercial aviation cycle continues its multiyear ramp-up, Howmet's margins move with it.
Axon Enterprise (NASDAQ: AXON) is the indirect aerospace and defense play that most people don't think of in that context. The company makes conducted energy weapons, body cameras, fleet management software, and AI-powered evidence tools for law enforcement and -- increasingly -- military applications.
In Q1 2026, Axon reported revenue of $807 million, up 34% year over year. The connection to the aerospace and defense spending cycle is real: Axon's expansion into drone countermeasures and autonomous surveillance tools positions it in a segment that the Department of Defense has prioritized as conflict modernization accelerates.
SpaceX is a bet on a future that may or may not materialize on the timeline the valuation assumes. The four companies featured above are bets on an aerospace industry that is already delivering, already profitable, and already backed by orders, backlogs, and government contracts that run years into the future.
The choice between them isn't really about risk tolerance. It's about whether you want to pay a premium for a story or pay a fair price for a business.
Before you buy stock in Space Exploration Technologies, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Space Exploration Technologies wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $382,359! Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,201,390!
Now, it’s worth noting Stock Advisor’s total average return is 883% — a market-crushing outperformance compared to 205% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
**Stock Advisor returns as of June 27, 2026. *
Micah Zimmerman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Axon Enterprise, Boeing, GE Aerospace, Howmet Aerospace, and TransDigm Group. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
Four leading AI models discuss this article
"SpaceX’s current valuation hinges on optionality that may not materialize on a timetable investors expect, making downside risk to the multiple real if profitability milestones slip."
The article correctly flags SpaceX’s losses and lofty multiple, but it underweights the upside optionality from a multi-stream model. Potential profitability could emerge from reusable-launch cost declines, Starlink enterprise/government monetization, and software/data services via xAI—streams that can produce durable, recurring margins even if hardware profits lag. Defense contracts and NASA programs add visibility to long-tailed revenue. The piece also glosses over external risks: regulatory scrutiny, competition in satellite internet, and the timing of profit realization. In short, the story isn’t binary: a steep premium could be justified if milestones hit; but the downside hinges on whether those levers actually scale when needed.
Strongest counter: if SpaceX hits scale on Starlink enterprise revenue, cost reductions from reuse, and defense deals on schedule, the premium could justify itself; the article’s caution may prove premature. Conversely, execution delays or regulatory hurdles could deflate the multiple quickly.
"SpaceX should be valued as an infrastructure utility for the orbital economy rather than a traditional aerospace manufacturer, making its current R&D burn a necessary investment for market dominance."
The article presents a classic 'value vs. moonshot' dichotomy, but it ignores the strategic moat SpaceX has built through vertical integration. While GE Aerospace, TransDigm, and Howmet are excellent plays on the commercial aviation supercycle, they are essentially suppliers to an oligopoly. SpaceX, conversely, is an infrastructure play that controls the launch market, effectively taxing the entire satellite and orbital economy. The $41.3 billion in losses cited are largely R&D and capital expenditure for Starship; comparing this to mature industrial manufacturers is an apples-to-oranges comparison of cash flow. If Starship achieves full reusability, the cost-per-kilogram to orbit drops by orders of magnitude, rendering the 'profitless' narrative obsolete as they move from heavy R&D to operational scale.
The strongest counter-argument is that SpaceX’s valuation requires flawless execution of Starship’s orbital refueling and high-cadence flight schedule, which faces significant regulatory and technical hurdles that could lead to a massive capital crunch.
"The article correctly identifies SpaceX's valuation risk but oversells the 'safer' alternatives by ignoring that aerospace suppliers are cyclical businesses whose current multiples already embed aggressive growth assumptions."
This article conflates two separate investment theses. SpaceX's $1.77T valuation is genuinely difficult to justify on traditional DCF metrics—Morningstar's $63 fair value implies 59% downside, and Q1 2026 losses of $4.28B are material. But the alternative thesis (GE, TDG, HWM, AXON) assumes a multiyear aviation supercycle without stress-testing cyclicality risk. Airlines deferred purchases during COVID; they'll eventually saturate fleet replacement. TransDigm's 25-year component revenue stream is real, but aerospace aftermarket cycles with utilization rates. The article presents this as 'already profitable' versus 'future bet,' but ignores that GE Aerospace, HWM, and TDG all have cyclical exposure—they're not immune to demand destruction if recession hits or if aircraft utilization drops.
If SpaceX achieves Starship commercialization and Starlink reaches profitability (both possible within 24-36 months), the $1.77T valuation could prove prescient; meanwhile, GE/TDG/HWM valuations already price in years of aviation growth and face margin compression risk if supply chain costs normalize or competition intensifies.
"SpaceX's vertical integration creates launch cost advantages that traditional aerospace DCFs systematically undervalue."
The article frames SpaceX as overvalued given $41.3B cumulative losses and a $4.28B Q1 2026 net loss, contrasting it with profitable aerospace names like GE, TDG, and HWM riding a commercial backlog supercycle. Yet this ignores how SpaceX's reusable launch economics and Starlink constellation scale could compress costs faster than legacy aftermarket models, creating asymmetric upside if Starship achieves cadence targets by 2027-2028. The four stocks offer visible earnings but limited exposure to orbital infrastructure growth.
Even if Starship succeeds technically, regulatory delays, launch competition from China, and sustained negative free cash flow could prevent any re-rating, leaving investors holding illiquid private shares far longer than the article's public alternatives require.
"Starship cadence and Starlink profitability must be proven; until then, the 'infrastructure moat' is not guaranteed, and costs could compress faster than expected, eroding value."
Gemini overstates the moat: reusable Starship helps, but scale hinges on sustained cadence, supply-chain stability, and favorable regulatory clears. Without proven profitability from Starlink enterprise/government deals, SpaceX risks remaining capital-intensive for longer than expected. If launch competition and satellite-costs compress faster than Starship’s efficiency, the so-called infrastructure moat may erode rather than expand. That keeps the stock/valuation thesis precarious until clear milestones prove operating leverage.
"SpaceX's valuation relies on unproven orbital refueling technology, making its 'infrastructure moat' a high-risk technical gamble rather than a guaranteed market capture."
Claude is right to flag the cyclicality of GE and TDG, but the panel is ignoring the most critical risk: the 'Starship-as-a-service' model is fundamentally dependent on orbital refueling. If that technical hurdle persists beyond 2026, the entire valuation thesis for SpaceX collapses regardless of launch cadence. We are debating infrastructure versus cyclicality while ignoring that SpaceX’s moat is currently a theoretical construct requiring physics breakthroughs, not just market share gains or operational efficiency.
"SpaceX's valuation requires simultaneous success in both orbital refueling and Starlink government revenue—either failure alone could crater the thesis."
Gemini's orbital refueling dependency is the crux, but we're underselling a parallel risk: Starlink's enterprise/government revenue scaling. SpaceX needs *two* simultaneous breakthroughs—Starship physics *and* Starlink monetization—not just one. If Starlink's government contracts (USSF, NATO) face budget cuts or delays, SpaceX loses the near-term cash bridge to fund Starship iterations. That dual-dependency hasn't been stress-tested here.
"Overlapping regulatory timelines for Starlink monetization and Starship refueling compound capital risk beyond isolated dual-dependency concerns."
Claude flags the dual Starship-Starlink dependency correctly, but this creates a tighter timeline trap than noted: Starlink government revenue must scale by 2026 to fund refueling iterations, yet simultaneous FAA and spectrum hurdles could delay both streams together. That overlap raises the probability of extended negative FCF past 2027, leaving the $1.77T valuation exposed to illiquidity far more than the aviation names' cyclical but visible earnings.
The panel consensus is bearish, with key concerns being the dual dependencies on Starship physics breakthroughs and Starlink monetization, and the risk of extended negative FCF past 2027.
Achieving proven profitability from Starlink enterprise/government deals and successful Starship cadence targets by 2027-2028.
Extended negative FCF past 2027 due to delayed Starlink monetization and regulatory hurdles.